Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification

Diagnostic Cytopathology

Volumn 40, Issue 5, 2012, Pages 410-415

  Horne, Matthew J ^a   Chhieng, David C ^a   Theoharis, Constantine ^a   Schofield, Kevin ^a   Kowalski, Diane ^a   Prasad, Manju L ^a   Hammers, Lynwood ^a   Udelsman, Robert ^a   Adeniran, Adebowale J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

fine needle aspiration; follicular lesion of undetermined significance; indeterminate; risk of malignancy; thyroid

Indexed keywords

ADULT; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER RISK; CLINICAL FEATURE; CYTODIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASM GRADING; TERMINOLOGY AS TOPIC; THYROID NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 84860636269     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21790     Document Type: Review

References (23)

1. Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: A necessary or optional category? Cancer Cytopathol 2009; 117: 298-304.
2. Weber D, Brainard J, Chen L,. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thyroid. Acta Cytol 2008; 52: 320-324 (Pubitemid 351705819)
3. Pitman MB, Cibas ES, Powers CN, et al. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear. Cancer 2002; 96: 128-134. (Pubitemid 34640946)
4. Layfield LJ, Cibas ES, Gharib H, et al. Thyroid aspiration cytology: Current status. CA Cancer J Clin 2009; 59: 99-110.
5. Marchevsky AM, Walts AE, Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol 2010; 38: 252-259.
6. Renshaw AA,. Reporting risk of malignancy/dysplasia in cytology: A potential way to improve communication, if not reputation. Cancer 2007; 111: 465-466. (Pubitemid 350304896)
7. Redman R, Yoder BJ, Massoll NA,. Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: A survey of clinicians and pathologists. Thyroid 2006; 16: 1003-1008. (Pubitemid 46141302)
8. Marhefka GD, McDivitt JD, Shakir KM, et al. Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: Does the result, benign vs. suspicious for a malignant process, in these nodules make a difference? Acta Cytol 2009; 53: 517-523.
9. Cibas ES, Ali SZ,. The Bethesda system for reporting thyroid cytopathology. Thyroid 2009; 19: 1159-1165.
10. Renshaw AA,. Focal features of papillary carcinoma of the thyroid in fine-needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol 2002; 118: 518-521.
11. Wu HH, Jones JN, Grzybicki DM, et al. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol 2003; 29: 262-266. (Pubitemid 37351942)
12. Renshaw AA,. Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 2010; 118: 186-189.
13. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: A summation. Cytojournal 2008; 5: 6
14. Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: Year 1 at an academic institution. Thyroid 2009; 19: 1215-1223.
15. Layfield LJ, Morton MJ, Cramer HM, et al. Implications of the proposed thyroid fine-needle aspiration category of "follicular lesion of undetermined significance": A five-year multi-institutional analysis. Diagn Cytopathol 2009; 37: 710-714.
16. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36: 425-437. (Pubitemid 351829800)
17. Ali SZ, Cibas ES,. The Bethesda system for reporting thyroid cytopathology. New York: Springer; 2010.
18. Adeniran AJ, Zhu Z, Ghandi M, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 2006; 30: 216-222. (Pubitemid 43740191)
19. Kelman AS, Rathan A, Leibowitz J, et al. Thyroid cytology and the risk of malignancy in thyroid nodules: Importance of nuclear atypia in indeterminate specimens. Thyroid 2001; 11: 271-277. (Pubitemid 32298425)
20. Alexander EK,. Approach to the patient with a cytologically indeterminate thyroid nodule. J Clin Endocrinol Metab 2008; 93: 4175-4182. (Pubitemid 352789508)
21. Layfield LJ, Abrams J, Cochand-Priollet B, et al. Post-thyroid FNA testing and treatment options: A synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36: 442-448. (Pubitemid 351829802)
22. Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111: 306-315.
23. Baloch Z, LiVolsi VA, Jain P, et al. Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules. Diagn Cytopathol 2003; 29: 203-206. (Pubitemid 37193647)